{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-056770","form_type":"8-K","ticker":"URGN","cik":"0001668243","company_name":"UroGen Pharma Ltd.","filed_at":"2024-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.045935+00:00","generated_at":"2026-06-05T04:46:26.743201+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"UroGen presents at TD Cowen conference; no material updates provided","bullets":["Presentation furnished as Exhibit 99.1 for TD Cowen 44th Annual Health Care Conference on March 4, 2024.","Title slide states: 'Developing Innovative Medicines to Treat Urothelial Cancers'.","No specific financial, clinical, or guidance data included in the filing or exhibit excerpt.","Filing is procedural Regulation FD disclosure; no new material events reported."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-056770","json":"https://secwatch.observer/filing/0001193125-24-056770.json","markdown":"https://secwatch.observer/filing/0001193125-24-056770.md","text":"https://secwatch.observer/filing/0001193125-24-056770.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1668243/000119312524056770/0001193125-24-056770-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1668243/000119312524056770/d743593d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T04:46:26.743201+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}